HopeStage
Back to all studies
RecruitingNCT05923801

Continue right-sided ECT or switch to bitemporal ECT after early nonresponse

About this titleRead the official source — NCT05923801
Device studyAges 18+BelgiumDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
KortenbergSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
196
Sponsor
Universitaire Ziekenhuizen KU Leuven
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
Belgium
Age range
Over 18 Years
Official registry ID
NCT05923801
Official title
Show the full official title

Changing Tactics? Optimizing ECT in Difficult-to-treat Depression: A Randomized Trial Comparing Continuation of Right Unilateral ECT and Switching to Bitemporal ECT in Case of Early Non-response During an Acute Course of ECT for Difficult-to-treat Depression

Recruitment & locations

Currently recruiting

Kortenberg

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Universitaire Ziekenhuizen KU Leuven.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies